跳至主要内容
临床试验/TCTR20220528005
TCTR20220528005尚未招募4 期

Efficacy and Safety of Autologous Fibroblasts on Acne Scars

Research department, Faculty of Medicine Siriraj Hospital0 个研究点目标入组 30 人开始时间: 2022年5月28日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Patients with moderate to severe acne scars in cheek areas by global acne scar grading system

排除标准

  • (1) were pregnant or lactating; (2) had a history of connective tissue disorder, skin cancers, or related diseases; (3) had previous autologous fibroblast treatment; (4) had previous treatment with fillers, lasers, or energy-based devices within the last 12 months; (5) had previous treatment using transdermal drug delivery, chemical peeling or topical retinoid within the last month; or (6) had an allergy to collagen, meat and dairy products, gentamycin, amphotericin B, or related products.

研究者

发起方
Research department, Faculty of Medicine Siriraj Hospital

相似试验